This federal contract award is for the delivery of BOTOX 200 unit vials to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The $3,492.78 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the large pharmaceutical distribution company Amerisourcebergen Corporation. This award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support...
This federal contract award is for the delivery of BOTOX 200 unit vials to the U.S. Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company, for a ceiling value of $23,285.20. The contract is a delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary...
This federal contract award is for the provision of BOTOX 200 UNIT VIALS to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense (DoD). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, under a Delivery Order valued at $5,821.30. The award has an ultimate completion date of May 6, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00...
This federal contract award is for the procurement of BOTOX 200 unit vials by the Defense Logistics Agency (DLA), a defense agency under the Department of Defense (DoD). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, through its Corporate Office Division. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $6,985.56. The award has an ultimate completion date of June 12, 2024. Amerisourcebergen holds a larger...
This federal contract award is for the delivery of BOTOX 200 UNIT VIALS to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $6,985.56 and an ultimate completion date of September 26, 2024. It is a Firm Fixed Price Delivery Order contract with no set-aside designation, indicating open competition....
This federal contract award is for the delivery of BOTOX 200 unit vials to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense (DoD). The contract, valued at $13,971.12, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company that serves as a prime contractor for the DLA. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of July 30, 2024. It is not designated as a set-aside contract....
This federal contract award is for the delivery of BOTOX 200 UNIT VIALS to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $13,971.12 and a completion date of May 23, 2024. The place of performance is Conshohocken, PA. This...
This federal contract award is for the delivery of BOTOX 200 unit vials to the Defense Logistics Agency (DLA), a defense agency that supports military healthcare programs. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price of $14,454.00 and a completion date of December 31, 2024. This award does not have a set-aside designation, indicating open competition....
This federal contract award is for the delivery of BOTOX 200 UNIT VIALS to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The $58,213.00 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on June 28, 2024. The contract has an ultimate completion date of July 22, 2024 and is not set aside for any specific business designation. Amerisourcebergen holds several large indefinite delivery contracts...
This federal contract award is for the delivery of BOTOX 200 UNIT VIALS to the Defense Logistics Agency (DLA). The contract was awarded to the prime contractor Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract has a ceiling value of $13,971.12 and is a Firm Fixed Price Delivery Order. It does not have a set-aside designation. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the...